Biosimilars: meet 2016’s solution to the specialty drug cost conundrum

If you work in the pharma or biotech industry, you’ve probably heard the buzz about biosimilars. And, there’s a good...

Read More

The dangerous delay in treating epilepsy patients

Imagine a mother, sitting in her living room, frantically calling a pharmacy, wondering why her son’s epilepsy...

Read More
Page 1 of 1